Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis*,**

https://doi.org/10.1016/S0049-0172(05)80037-XGet rights and content

Quantitative bone scan (QBS), computed tomography (CT), and magnetic resonance imaging (MRI) have each been used to confirm the diagnosis of active sacroiliitis (SI) in patients with low back pain (LBP). The authors prospectively evaluated 19 patients referred for symptoms of possible inflammatory LBP (group I), 26 seronegative spondyloarthropathy (SNSP) patients with LBP (group II, inflammatory or mechanical), and 5 SNSP patients without LBP (group III) to determine which radiological scan, alone or in combination with other serological tests (Westergren erythrocyte sedimentation rate, C-reactive protein, HLA-B27, immunoglobulin A) was most useful in confirming a clinical diagnosis of active inflammatory SI. All patients were followed up for a minimum of 1 year to confirm the clinical diagnosis and evaluate response to therapy. Eight of 19 group I patients had active SI clinically or on plain radiographs on follow-up evaluation. Of these patients, 5 had abnormal QBS (71%), 3 had abnormal CT scans (38%), and 8 had abnormal MRI scans (100%, type I lesions). These type I MRI lesions were indicative of active inflammation manifested as subcortical bone marrow edema. The remaining 11 group I patients had negative scans for SI. Ten of 26 group II patients with LBP had SI diagnosed clinically and confirmed with positive QBS (60%), CT (100%), and MRI (100%, type I lesions). The remaining 16 group II patients had mechanical LBP without active SI clinically and had negative QBS (88%), CT (19%), and MRI (100%, normal or type II lesions). These type II MRI lesions represented old postinflammatory lesions with either fibrosis or fat replacement. All 5 group III patients had negative scans for active SI. Three patients (2 group I and 1 group II) with inflammatory SI treated with sulfasalazine showed marked improvement on serial MRI scans. Westergren erythrocyte sedimentation rate, C-reactive protein, immunoglobulin A, and CT scan alone or in combination with other tests were not reliable predictors of active SI. Positive QBS and HLA-B27 tests were the best combination of screening tests with 82% predictability of inflammatory SI in whites, and QBS alone had an 80% predictability in black patients. However, MRI, which had 100% predictability, was the best single test for confirming active inflammatory SI.

References (52)

  • KhanMA et al.

    A wider spectrum of spondyloarthropathies

    Semin Arthritis Rheum

    (1990)
  • ScottDGI et al.

    Problems in the assessment of disease activity in ankylosing spondylitis

    Rheumatol Rehabil

    (1981)
  • MollJMH et al.

    Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome

    Medicine (Baltimore)

    (1974)
  • WrightV

    Seronegative polyarthritis: A unified concept

    Arthritis Rheum

    (1978)
  • ArnettFC

    Seronegative spondylarthropathies

    Bull Rheum Dis

    (1987)
  • BennettPH et al.
  • MollJMH et al.

    New York clinical criteria for ankylosing spondylitis. A statistical evaluation

    Ann Rheum Dis

    (1973)
  • van der LindenSM et al.

    Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

    Arthritis Rheum

    (1984)
  • KhanMA et al.

    Spondylitic disease without radiologic evidence of sacroilitis in relatives of HLA-B27 positive ankylosing spondylitis patients

    Arthritis Rheum

    (1985)
  • ZeidlerH

    Undifferentiated arthritis and spondylarthropathy as a major problem of diagnosis and classification

    Scand J Rheumatol

    (1987)
  • MauW et al.

    Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup

    J Rheumatol

    (1988)
  • CalinA et al.

    Clinical history as a screening test for ankylosing spondylitis

    JAMA

    (1977)
  • RussellAS et al.

    Clinical examination of the sacroiliac joints: a prospective study

    Arthritis Rheum

    (1981)
  • BlowerPW et al.

    Clinical sacroiliac tests in ankylosing spondylitis and other causes of low back pain—2 studies

    Ann Rheum Dis

    (1984)
  • CowlingP et al.

    C-reactive protein, ESR, and Klebsiella in ankylosing spondylitis

    Ann Rheum Dis

    (1980)
  • DixonJS et al.

    A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis

    Ann Rheum Dis

    (1981)
  • LaurentMR et al.

    Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis

    Ann Rheum Dis

    (1983)
  • FranssenMJAM et al.

    IgA serum levels and disease activity in ankylosing spondylitis: a prospective study

    Ann Rheum Dis

    (1985)
  • NashelDJ et al.

    C-reactive protein: A marker for disease activity in ankylosing spondylitis and Reiter's syndrome

    J Rheumatol

    (1986)
  • SheehanNJ et al.

    Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis

    Br J Rheumatol

    (1986)
  • SandersKM et al.

    Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis

    Ann Rheum Dis

    (1987)
  • TaylorHG et al.

    The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis

    Br J Rheumatol

    (1991)
  • RussellAS et al.

    Investigation of sacroiliac disease: comparative evaluation of radiological and radionuclide techniques

    J Rheumatol

    (1975)
  • SzantoE et al.

    Detection of sacro-iliitis

    Scand J Rheumatol

    (1977)
  • NameyTC et al.

    Nucleographic studies of axial spondarthritides

    Arthritis Rheum

    (1977)
  • GoldbergRP et al.

    Applications and limitations of quantitative sacroiliac joint scintigraphy

    Radiology

    (1978)
  • Cited by (0)

    *

    Presented in part at the 56th Annual American College of Rheumatology Meeting, October 14, 1992, Atlanta, Georgia.

    **

    The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Anny or Department of Defense.

    1

    From the Rheumatology and Radiology Departments, Fitzsimons Army Medical Center, Aurora, CO.

    2

    Daniel F. Battafarano, DO: Staff Rheumatologist, Department of Rheumatology

    3

    Sterling G. West, MD: Chief of Rheumatology, Department of Rheumatology

    4

    Kevin M. Rak, MD: Chief of Musculoskeletal Radiology, Department of Radiology

    5

    Edwin J. Fortenbery, MD: Assistant Chief of Nuclear Medicine, Department of Radiology

    6

    Allen E. Chantelois, MD: Chief of Computed Tomography, Department of Radiology

    View full text